Related by context. All words. (Click for frequent words.) 67 Grouped Hockey 63 potent bactericidal killing 63 SuperMedia specializes 62 TransVax ™ 61 CYT# potent vascular disrupting 61 Wrestling Wrap Up 61 radezolid 60 pharmacodynamic parameters 60 dose proportionality 60 preclinical efficacy 60 velafermin 60 evaluating tivozanib 60 MERIT ES 60 relapsed MM 60 abysmal Shaiken 60 drilling wireline logs 60 Rigorous scientific 60 preclinical xenograft models 60 antiangiogenic activity 60 Vaxfectin R 60 microbiology immunology epidemiology 60 mg/m2 cohort 60 Zemplar Capsules 60 enzyme immunoassay EIA 60 pharmacodynamic markers 60 favorable pharmacokinetic profile 60 Ameris Bancorp Reports 60 Vaxfectin R adjuvant 59 linear pharmacokinetics 59 Pharmacokinetic parameters 59 Meta analyzes 59 Pharmacodynamic 59 demonstrated clinically meaningful 59 Phase #/#a trial 59 hematological tumors 59 delafloxacin 59 Improved Second Quarter 59 Thiovir 59 vitro antiviral 59 TLR antagonists 59 CRLX# 59 Cardiotoxicity 59 crizotinib PF # 59 Histopathologic 59 kidney urologic 59 mean ± SEM 59 quantitative cytology 59 CINQUIL 59 Aeolus Pharmaceuticals Announces 58 Photodisinfection provides 58 fusion enhancers 58 human tumor xenografts 58 cMET 58 Power3 Alzheimer disease 58 pharmacokinetics pharmacodynamics 58 antiangiogenic agents 58 angiotensin analog 58 lymphoid tumors 58 fluoroquinolone antibiotic 58 4CMenB 58 Misys Healthcare Experience 58 evaluating REVLIMID 58 OVA1 ® 58 prospective multicentre 58 Multivariate logistic regression 58 asthma immunotherapeutic 58 Vaxfectin TM 58 Zalypsis 58 AirBoss Announces 57 hemagglutination inhibition HAI 57 Parlay Entertainment Announces 57 circulating endothelial cells 57 demonstrated antitumor activity 57 Oral NKTR 57 ELISpot 57 CTA# Injection 57 antimicrobial efficacy 57 MET amplification 57 optical biosensors 57 antimitotic 57 MenACWY 57 recurrent metastatic ovarian cancer 57 oral picoplatin 57 non squamous histology 57 prospective observational studies 57 trastuzumab DM1 T DM1 57 eTag assays 57 Vaxfectin 57 radiolabeled TM# 57 clinico pathological 57 intradialytic hypotension IDH 57 Adtegrity.com Reports 57 Tß4 57 LAB CGRP 57 exploratory endpoints 57 Pharmacokinetic PK 57 TÎ ² 4 57 alicaforsen enema 57 probiotic supplementation 57 biotransformed blueberry juice 57 teriflunomide 57 bactericidal activity 57 relapsed MCL 57 pharmacokinetic PK profile 57 Chlamydia trachomatis infection 57 Warfarin Coumadin 57 NEUVENGE 57 lipid altering 57 Antigenics QS 57 BEXXAR Therapeutic Regimen 57 TriGrid 56 RRM1 56 tolerability pharmacokinetics 56 Cardiorespiratory fitness 56 DAS# scores 56 electrophysiologic 56 blood coagulation disorders 56 Multiple logistic regression 56 CIMZIA ™ 56 Outpatient Setting 56 NovaBay Aganocide compounds 56 TOFUTTI Announces 56 APTIVUS r 56 Ceragenin ™ 56 chronic periodontitis 56 specified secondary endpoints 56 potent antiviral 56 antitumour 56 TABLE #.OS -#/# parent 56 maximally tolerated dose 56 vitro ADME 56 anti MRSA cephalosporin 56 selenium supplementation 56 Alternans 56 Histologic 56 pramlintide metreleptin combination 56 AVI BioPharma Announces 56 pegylated alpha interferon 56 immunotherapeutic approaches 56 myopathy rhabdomyolysis 56 potent antitumor activity 56 Exelixis compounds 56 NEUGENE 56 microRNA profiling 56 panitumumab Vectibix 56 K ras mutations 56 pemetrexed Alimta 56 ALISTA 56 PORxin TM platforms 56 Statistically Significant Improvement 56 BC SeraPro ™ 56 Pandemic Threats Represents 56 serum phosphorous 56 pharmacokinetic pharmacodynamic 56 Symadex 56 Demonstrates Positive 56 tissue microarrays 56 haematologic 56 avosentan 56 methylation markers 56 my3KG 56 Shows Promising 56 ORAL Solo 56 EEG abnormalities 56 duplex ultrasonography 56 EQUETRO 56 parasitological 56 PreCISe 56 metabolite identification 56 Idenix Pharmaceuticals Reports 56 #th Annual Interscience 56 trials RCTs 56 potent anti angiogenic 56 molecular biomarker 56 See CLINICAL PHARMACOLOGY 56 pharmacokinetic PK study 56 #rd Annual CTRC 56 BACcel 56 genotypic resistance 56 HuMax CD#b 55 Solorel TM 55 botanically derived 55 LEAPS TM 55 viral kinetics 55 Antitumor 55 plasma lipid 55 retaspimycin 55 Immunogenicity 55 trastuzumab Herceptin ® 55 HIV RDEA# 55 TRAIL R1 55 LungAlert TM 55 BCR ABL tyrosine kinase 55 Telik Announces 55 serum leptin 55 tumor subtypes 55 behavioral neurobiology 55 MMP inhibitors 55 antiepileptics 55 intravascular hemolysis 55 BRIM3 55 peptide conjugated 55 prenatal exposures 55 next generation URAT1 55 immunomodulating 55 rxRNA 55 myelofibrosis polycythemia vera 55 Ganetespib 55 JAK inhibitors 55 BACcel ™ system 55 Tesmilifene 55 Evoltra ® 55 FOLPI 55 virologic responses 55 Combination REOLYSIN R 55 Gastrointestinal Stromal Tumors 55 Virulizin ® 55 oncolytic virus therapies 55 thorough QT 55 bronchial lavage 55 Genotypic 55 anti leukemic 55 PIB PET 55 immunological responses 55 Phase 1a clinical 55 XR NTX 55 tolerability profiles 55 TQT studies 55 Nymox Reports 55 qNPA 55 preclinically 55 non nucleoside HCV 55 Non inferiority 55 multiple logistic regression 55 Aganocide 55 INTEGRILIN R eptifibatide Injection 55 SPRYCEL ® 55 Techni lab 55 concomitant plasma glucose 55 Bayer HealthCare Onyx Pharmaceuticals 55 viral tropism 55 pharmacogenetic tests 55 nucleic acid isolation 55 lesional 55 Salix Pharmaceuticals Announces 55 antiviral efficacy 55 concomitant medications 55 NLX P# 55 topical NSAIDs 55 genomics proteomics biosensors 55 Bcr Abl mutations 55 pharmacokinetic characteristics 55 lipid parameters 55 Secondary efficacy endpoints 55 random suspicionless employee 55 Immunomedics Announces 55 flavopiridol 55 Active Ulcerative Colitis 55 diagnostic molecular imaging 55 mechanistic studies 55 evaluating mipomersen 55 logistic regression analyzes 55 genomic biomarkers 55 Vaxfectin ® 55 immune modulating 55 blood serum biomarkers 55 APTIMA HPV assay 55 OYO Geospace Reports 55 gallium nitrate 55 KineMarker TM 55 CCX# 55 eco toxicological 54 Valhi Reports 54 Relapsed Multiple Myeloma 54 drug metabolizing enzymes 54 Resurgex Plus R 54 XPEL Announces 54 OBPM 54 Tumor Response 54 dose proportional pharmacokinetics 54 Triolex 54 DermaPrep 54 posttest 54 neurosensory 54 darbepoetin alpha 54 pharmacodynamic effects 54 secretory phospholipase A2 sPLA2 54 Antitumor Activity 54 GlobalSpec Industrial 54 ANAVEX #-# [002] 54 Bioheart MyoCell 54 stage hypoxia activated 54 ConclusionThis 54 BAL# [002] 54 Transdermal Delivery 54 AST ALT 54 fluoroquinolone resistance 54 Harpo Studios produces 54 Prostate AdenoCarcinoma Treatment 54 bepotastine besilate nasal spray 54 Adverse effects 54 cagA 54 Tasigna prolongs 54 neuronal nicotinic receptor NNR 54 AdVac ® 54 System IPSS 54 DDW ® 54 deCODE BreastCancer 54 preclinical pharmacokinetic 54 biochemical profiling 54 IMPROVE HF 54 Macrolide 54 -#.# log# copies mL 54 containing abacavir 54 vivo efficacy 54 sapacitabine CYC# 54 beta lactam antibiotic 54 telomerase inhibitor 54 metabolomic profiling 54 histologies 54 HER2 expression 54 NMR LipoProfile test 54 Disclaimer Sport# encourages 54 HER2 overexpression 54 pulp metallic 54 biologic plausibility 54 Vaxfectin adjuvant 54 HCV protease inhibitors 54 DAS# [001] 54 Bionate ® PCU 54 PORxin TM 54 AVERROES 54 recombinant PSMA vaccine 54 novel topical reformulations 54 vivo preclinical 54 telemonitoring imaging 54 immunohistochemical analysis 54 torsemide ER 54 Pre Exposure Prophylaxis 54 Carrier Ethernet IP MPLS 54 ACCORD Lipid 54 Vaxfectin TM adjuvant 54 Preclinical Study 54 address untreatable bioterror 54 protease inhibitors PIs 54 clinicopathological 54 tumor necrosis 54 florbetaben 54 CAMMS# 54 inhibin B 54 alpha7 54 secondary efficacy endpoints 54 anticancer activity 54 multicenter multinational 54 IgE antibody 54 S. aureus isolates 54 patient subpopulations 54 antitumour activity 54 Gag polymorphisms 54 potent inhibitory 54 Subgroup analyzes 54 pleiotropic 54 Atopic Dermatitis 54 mg q#h 54 antiviral antibacterial 54 PIK3CA 54 near infrared spectroscopic 54 bronchodilatory 54 CCR5 receptor antagonist 54 Immunotherapeutic 54 potent antiproliferative 54 tiagabine 54 pyridostigmine 54 breast cancer subtypes 54 DCE MRI 54 vertigo dizziness 54 glycosylated hemoglobin HbA1c 54 Histopathological 54 Buglova 54 ovarian endometrial 54 RNAi therapeutic platform 54 histological subtypes 54 DNAWitness Mito 54 Outcome Measures 54 biodefense pathogens 54 Symptom severity 54 Epothilones 54 pharmacodynamic PD 54 proteins peptides 54 Novavax VLP vaccine 54 #T# L1 54 Disclaimer News# encourages 54 radiotracer uptake 54 Flow cytometry 54 molecular biology genomics proteomics 54 BY DAVID CRIGGER 54 PI3K Akt 54 AMWO 54 protein biomarker discovery 54 pharmacodynamic endpoints 54 SynCon ™ DNA 54 development diagnostics combinatorial 54 malignant mesothelioma Alfacell 54 lymphomas leukemias 54 quinolone resistant 54 neuropathologic 54 CanAg 54 electroencephalographic EEG 54 PCI ExTRACT TIMI 54 clade B 54 SIRT1 activation 53 Randomized trials 53 Traficet EN 53 R#/MEM # 53 PENNVAX B 53 Anti Bacterial Envelope 53 LT NS# 53 GH deficiency 53 SYMMETRY trial 53 miRNA expression 53 Endocrine Society #st 53 antimicrobial susceptibility 53 Sangamo BioSciences Announces 53 SinuNase ™ 53 antiapoptotic 53 drug metabolism bioavailability 53 VP# [004] 53 intranasal delivery 53 CPS ASEC 53 antiretroviral naïve 53 hematological parameters 53 IMiDs ® 53 antiplatelet medications 53 Serologic 53 Oil Dri Announces 53 ANCHOR trial 53 Cites Positive 53 Anthracycline 53 ritonavir boosted 53 AVN# Phase 53 SIRT1 activators 53 BRIM2 53 Phase 1b clinical trials 53 cognitive behavioral therapies 53 d l leucovorin 53 AAGP TM 53 ZFP TFs 53 number NCT# ClinicalTrials.gov 53 methodologically rigorous 53 gene expression assays 53 novel emulsion formulation 53 Adnectin 53 Kaplan Meier curve 53 CYP#A# substrate 53 investigational therapies 53 ARTHRITIS AQUATIC PROGRAM 53 Momenta Pharmaceuticals Announces 53 blinded randomized placebo controlled 53 Vicor Technologies Announces 53 Insulin PH# 53 therapeutic monoclonal antibodies 53 NNRTI resistant 53 tramiprosate Alzhemed TM 53 induced tumor regression 53 tamoxifen Nolvadex ® 53 Pharmacokinetic 53 Inovio proprietary electroporation 53 include interoperability conformance 53 proton MR spectroscopy 53 Prodarsan ® 53 γ secretase 53 PROSTVAC VF 53 Ceplene/IL-2 53 Thalomid ® 53 Univariate analysis 53 AgaNase 53 Immune responses 53 bacterial fungal 53 Post hoc 53 hematological tumor 53 Drospirenone 53 INCB# [001] 53 pharmacokinetics PK 53 Alequel 53 neuroimaging studies 53 topical anti infectives 53 E. faecalis 53 Phase Ib II 53 GLP toxicology studies 53 nonbacterial prostatitis 53 Sentinel Lymph Node Biopsy 53 dose pravastatin 53 Western Blotting 53 formerly LymphoStat B 53 multitargeted 53 Hematologic 53 Thymosin Beta 4 53 CaPre TM 53 brachial artery flow 53 Oral contraceptive 53 clinical trials XIFAXAN 53 allergic airway inflammation 53 AMB IBI 53 Fludara ® 53 Isavuconazole 53 Bipolar sufferers 53 clinicopathologic 53 ORAL Sync 53 recombinant spider silk 53 statistically significant superiority 53 CYP#D# inhibitor 53 left ventricular diastolic 53 preclinical toxicology 53 thalidomide Thalomid 53 ritonavir boosted protease inhibitor 53 antibiotics antifungals 53 Disclaimer News# 53 MAGE A3 ASCI 53 Dr. Gabriel Lasala 53 EFP weapon 53 ImmunoVEX HSV2 53 echocardiographic parameters 53 LungCAD TM software 53 pharmacodynamic properties 53 Hematologic toxicity 53 BARACLUDE R 53 ACR# ACR# 53 Simulations Plus Reports 53 varenicline Chantix 53 reporting purposes nonreportable 53 multiplex assays 53 DanceCenter segment parody 53 BBSI provides 53 Zicam Cold Remedy Chewables 53 xi unanticipated 53 sirtuin activators 53 Secondary endpoints include 53 Apoptone 53 HIV HCV coinfected 53 surgical prophylaxis 53 Gilead Viread 53 PDE4 modulators 53 NRF2 gene 53 cosmetic cosmeceutical products 53 website www.novavax.com 53 antitumoral 53 JAK2 inhibitors 53 MEK inhibitors 53 dose escalation phase 53 RIO Diabetes 53 tumor histology 53 injectable inhaled 53 multiplex biomarker 53 APTIVUS 53 Prodarsan R 53 Peregrine Pharmaceuticals Reports 53 encapsulates siRNAs 53 caustic fusion diamond 53 carbohydrate polymers 53 IFN α 53 tumor xenografts 53 Tr DNA 53 eczema atopic dermatitis 53 HCV antibody 53 OUTLOOK Highlights 53 orally bioavailable mimics 53 MYDICAR ® 53 Mutational 53 tipranavir ritonavir 53 Selembu shows 53 Virological 53 histopathological 53 CYP#D# genotype 53 Immunohistochemical 53 purinergic receptors P#X# 53 semi synthetic lipoglycopeptide 53 Confirmatory tests 53 Ashworth Scale 53 programs FSN televises 53 trans palmitoleate 53 potent suppressor 53 nonpharmacologic 53 NEUGENE antisense 53 barbiturates benzodiazepines 53 BHT DNA 53 Myriad Flurizan 53 aplindore 53 CVx ChannelVision Expo 53 rALLy trial 53 pharmacodynamic 53 Inovio DNA 53 inhaled bronchodilators 53 EGFR antibodies 53 KRAS status 53 EDEMA3 trial 53 Monogram Trofile TM 53 segmented regionally 52 Accelr8 Announces 52 Corus CAD 52 liposome formulation 52 #S rRNA gene 52 Anti Tumor Activity 52 drilling recompletions 52 VIDAZA ® 52 IgG antibody 52 qualitative serum 52 visit www.genenews.com 52 doxorubicin cyclophosphamide 52 perfusion MRI 52 Detrol Detrol LA 52 anti infective therapeutic 52 Protease Inhibitors 52 HORIZONS AMI trial 52 Selzentry Celsentri 52 papillary renal cell carcinoma 52 telomerase inhibition 52 Pfizer reanalyzed 52 TOLAMBA 52 favorable pharmacokinetic 52 antimetabolites 52 Sipuleucel T 52 phylogenetic analyzes 52 renal cortical 52 Heska Announces 52 protein kinase inhibitors 52 beta lactamase inhibitor 52 Los Santillan 52 lymphoma subtypes 52 proteomics bioinformatics 52 immune stimulatory 52 Univariate 52 nonfasting 52 gefitinib Iressa 52 METOZOLV ™ ODT metoclopramide 52 chemopreventive agents 52 Secession Ball falls 52 detection reagents 52 Zevalin consolidation 52 nontraditional ISR role 52 AGHD 52 tumorigenicity 52 multivariate regression analysis 52 headache abdominal pain 52 vitro potency 52 antibiofilm 52 sang Ramblin Fever 52 redox active 52 toxicogenomic 52 Tori Spelling Garage Sale 52 aluminosilicate clay 52 DASISION 52 mineralized uncut 52 microarray gene expression 52 Dose Finding 52 leukotriene receptor antagonist 52 colorectal carcinogenesis 52 LifeVantage Announces 52 bovine thrombin 52 Crofelemer budesonide foam 52 IgG1 antibodies 52 chlamydial infection 52 CIMZIA TM certolizumab pegol 52 microbiologic 52 foods insect stings 52 topical antimicrobial 52 preliminary cyanide amenability 52 sputum induction 52 including eniluracil ADH 52 MGN# 52 antimetastatic activity 52 GERD migraine headaches 52 pharmacokinetic parameters 52 Anidulafungin 52 Clinical Trial Results 52 serologic tests 52 enzyme inhibition 52 drilldown capabilities 52 Skin sterol 52 TPMT 52 triple nucleoside regimen 52 Vertebral Fractures 52 Newly Diagnosed Multiple Myeloma 52 cardio metabolic diseases 52 Phylogenetic analyzes 52 biostatistical analysis 52 Inovio electroporation 52 Original HP LaserJet 52 hepatic lesions 52 comparative genomic analysis 52 TTR amyloidosis 52 immunological disorders 52 Claimsnet.com Reports 52 catheter ablations 52 coinfected patients 52 vitro dissolution 52 pharmacodynamic profiles 52 convergent validity 52 pharmacokinetic interactions 52 TRV# [001] 52 ALB # 52 Match Fixtures 52 Ov er ra ted 52 Vancocin R 52 endpoint assays 52 topical antifungal 52 solid tumors ZYBRESTAT 52 vitamins minerals amino acids 52 Oncotype 52 surveys Herbenick 52 potent recombinant 52 peptides proteins 52 Cortisol levels 52 www.vicortech.com 52 serum cortisol 52 abnormal cytology 52 HEPLISAV TM hepatitis B 52 highly adaptable WFO 52 cyclic HMB 52 NSABP B 52 synDNA TM 52 Encision Reports 52 REAs Rich Enterprise 52 synthetic peptides 52 Pharmacologic 52 placebo controlled clinical trials 52 oral rivaroxaban 52 completely resected 52 A3 adenosine receptor 52 CBLB# mechanism 52 Tocomin ® ™ 52 liposomal formulations 52 ZFP Therapeutics 52 interindividual variability 52 follicular lymphoma FL 52 better childproof containers 52 Thyroid nodules 52 GI motility disorders 52 EndoTAG TM 52 Janis Joplin soundalike respiratory 52 comparative genomic 52 Profitable Third Quarter 52 Beastie Boys Intergalactic Produced 52 WARNINGS Myopathy Rhabdomyolysis 52 nm transceiver 52 liver cancers hypercholesterolemia 52 Atkins dieters cardiovascular 52 TNF alpha selectively neutralizing 52 inferential statistics 52 obj obj = 52 AVI antiviral programs 52 Cerashield ™ 52 Beta lactam antibiotics 52 AZT zidovudine Retrovir 52 Serological 52 erection hardness 52 urocortin 2 52 CobaCyte 52 NNRTI resistant virus 52 NHANES III 52 CompX Reports 52 visiting www.epicept.com 52 pharmacogenetic testing 52 metaanalysis 52 EMCORE Photovoltaic segment 52 Farfan Juan Pablo 52 vaccine RiVax TM 52 By Priyanka Dayal 52 HCV SPRINT 52 Vascugel ® 52 RE MODEL 52 Shows Efficacy 52 NuroPro ® 52 BioVant 52 Rosetta Genomics microRNA 52 RE LY ® 52 printmaking ceramics 52 metabonomics 52 cytoreductive nephrectomy 52 ETEC vaccine 52 FOREXYARD Daily Forex 52 anti Parkinsonian 52 nonsampling errors 52 HPAPIs 52 SHOWS TO WATCH 52 EGFR expression 52 tropism testing 52 spirometric 52 neuropsychiatric diseases 52 Emorys lived 52 Anticalins R 52 NUVIGIL ® 52 Gastineau gyms open 52 beta lactams 52 Cystatin C 52 Aldean Shelton 52 Lp PLA 2 52 Highly anomalous 52 inflammatory biomarkers 52 myeloproliferative diseases 52 ALTANA develops 52 Achieves Primary Endpoint 52 AAGP ™ 52 soluble beta amyloid 52 gastric retentive 52 Adhesive strips 52 Altera Nebulizer System 52 serum antibodies 52 Inter Citic Reports 52 Serum calcium 52 Randomized controlled 52 Hedgehog inhibitor 52 antiviral potency 52 based proprietary bioceutical 52 phase IIb study 52 hemodynamic measurements 52 using Crucell PER.C6 52 NRTI resistance 52 molecular diagnostic reagents 52 tPA antithrombotics anticoagulation therapy 52 nucleoside analogs 52 #T# tumor 52 peptibody 52 ADME properties 52 Randomized Clinical Trials 52 amphetamine methamphetamine 52 CYP#A# CYP#D# 52 Microarray analysis 51 MEND CABG 51 CME CE 51 serum biomarkers 51 creatine supplementation 51 Cash Dividend Declared 51 ChromoCure develops 51 LabCorp conducts clinical trials 51 Orthokine 51 Validity biometric security 51 PK PD modeling 51 Amgen discovers develops 51 Doug Speheger 51 Natural Catastrophe Stress 51 morphometrics 51 palm tocotrienol complex 51 intensive lipid lowering 51 imatinib resistance 51 RECORD1 51 GetGoal Phase III 51 Pre RELAX AHF 51 Wisconsin Sleep Cohort 51 British dadA 51 ToleroMune 51 bone spurs bulging 51 latent tuberculosis TB 51 tumor regressions 51 prostate abnormalities 51 Phase IIA 51 Negative Symptoms 51 bacterial isolates 51 hematologic parameters 51 genotype phenotype 51 Coronary Artery Calcium 51 Deforolimus 51 Invasive pneumococcal disease 51 DuPont http:/www.dupont.com 51 hydrophobic docetaxel prodrug nanoparticle 51 OTHER WOOD PRODUCTS 51 PremierWest Bancorp Announces 51 TDF FTC 51 www.chesapeakelodgingtrust.com 51 p# alpha [001] 51 P. falciparum parasites 51 AbitibiBowater produces 51 becoming growingly numb 51 retinoid X 51 pharmacokinetic equivalence 51 MassARRAY R 51 human alpha interferon 51 torsade de pointes 51 prolonged QT interval 51 mass indexes BMIs 51 Renal Cell Carcinoma RCC 51 vivo toxicology 51 phage display libraries 51 Enzo Biochem Reports 51 neutralizing antibody titers 51 VIQ Solutions Reports 51 Antioxidant supplements 51 prospective observational cohort 51 dentin hypersensitivity 51 R roscovitine 51 CIPN 51 proprietary biomaterials 51 microbiomes 51 pharmaceutical excipients 51 ANAVEX #-# [001] 51 alpha interferons 51 Phase 2b Clinical Trial 51 noninfectious uveitis 51 antisense inhibition 51 Fluoroquinolones 51 MacroChem actual 51 CP CPPS 51 commercialize ZYFLO CR 51 Anticalins 51 prospectively stratified 51 immunofluorescent 51 SEISMIC Trial 51 extramarital affairs flunk 51 sputum specimens 51 nevirapine Viramune 51 genomewide association study 51 physicochemical 51 THCA represents 51 Cluuz search 51 Archexin 51 Oncotype DX ® 51 pharmacoeconomic 51 FDG PET imaging 51 phase Ib 51 xTAG RVP 51 cis regulatory 51 Los Angeles KJLA 51 ThermoDox ® clinical 51 mitiglinide 51 vivo assays 51 P#X# antagonist 51 Daptomycin 51 VYVANSE demonstrated 51 MEMSIC Announces 51 EMPOWER TM 51 Cathepsin B 51 Posiphen ® 51 Antigenic 51 specific antigen PSA 51 De Pelicula Clasico 51 empiric therapy 51 nonnucleoside reverse transcriptase inhibitors 51 BY SHANNON COLAVECCHIO 51 Oral Mist 51 meta regression 51 ANCOVA 51 antibody mediated 51 Nanobodies ® 51 phosphorylated tau 51 PetroQuest Energy Announces 51 Viral load 51 antiemetics 51 printmaking photography 51 VANOS TM 51 salivary cortisol 51 biologists chemists materials 51 hypereosinophilic syndrome 51 transcriptomic 51 genotoxicity studies 51 molecular imaging radiopharmaceuticals 51 NESARC 51 virosome 51 Spectrum Pharmaceuticals Announces 51 dermaceuticals 51 MultiStat 51 KRAS variant 51 conditional logistic regression 51 Fireworks resounded 51 Stab stab 51 cardiac perfusion 51 bioprocesses 51 therapeutic monoclonal antibody 51 Barnsley Doncaster Rovers 51 hematopoietic cancers 51 Gadavist 51 priority biodefense pathogens 51 inattention hyperactivity 51 tendon dislocated shoulder 51 Cooked tomatoes 51 O PPDS 51 Its extraordinariness fades 51 Genedata Phylosopher ® 51 Bronchial Thermoplasty 51 efalizumab 51 protein tyrosine phosphatase 1B 51 linaclotide treated 51 include ColorectAlert TM 51 transaminase elevations 51 antiangiogenic agent 51 Search amNY.com Web 51 AGGRASTAT ® tirofiban hydrochloride 51 INS# [001] 51 OSMOPREP 51 MAG Silver Reports 51 NATIONAL ECONOMIC COUNCIL DIRECTOR 51 IV RSD# 51 bin Abi Farag 51 colonoscopy sigmoidoscopy 51 agonist antagonist 51 DataFlux enables 51 toxicologic 51 NovaDel oral spray 51 HIV uninfected 51 BRAF V# mutation 51 #dhTxB#